University of Michigan Scleroderma Program - Division of Rheumatology/Dept. of Internal Medicine is a clinical research site located in Ann Arbor, Michigan, United States 48109.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
University of Michigan Scleroderma Program - Division of Rheumatology/Dept. of Internal Medicine has participated in 1 clinical trials.
Therapeutic areas: Raynaud's Phenomenon Secondary to Systemic Sclerosis.
Sponsors: NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.).
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Michigan Scleroderma Program - Division of Rheumatology/Dept. of Internal Medicine has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Michigan Scleroderma Program - Division of Rheumatology/Dept. of Internal Medicine has 1 clinical trials on record. Their work covers Raynaud's Phenomenon Secondary to Systemic Sclerosis.
University of Michigan Scleroderma Program - Division of Rheumatology/Dept. of Internal Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.